FOXA2 in cancer: from fundamental biology to clinical translation - Takeaways - MDSpire

FOXA2 in cancer: from fundamental biology to clinical translation

  • By

  • Yongran Xia

  • Peng Liang

  • Lijuan Cui

  • Yu Cao

  • May 28, 2026

  • 0 min

Share

  • 1

    FOXA2 is a crucial transcription factor involved in organ development and metabolic regulation, impacting various cancers.

  • 2

    Dysregulated FOXA2 expression can act as either an oncogene or tumor suppressor, depending on the cancer type.

  • 3

    FOXA2 influences malignant phenotypes through mechanisms like epithelial-mesenchymal transition and immune checkpoint modulation.

  • 4

    The review highlights FOXA2's potential as a diagnostic and prognostic biomarker in oncology.

  • 5

    Future therapeutic strategies may target FOXA2 or its regulatory pathways to improve cancer treatment outcomes.

Original Source(s)

FOXA2 in cancer: from fundamental biology to clinical translation

  • by Yongran Xia, Peng Liang, Lijuan Cui, Yu Cao

  • May 28, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Differentiation of hepatocellular carcinoma from hepatic hemangioma using diffusion-derived vessel density map-based radiomics features

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen